Role of steroid 11,6-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans (cortisol (9) recently isolated aldosterone synthase cytochrome P-450 (P-450ado), which is induced in Na+-depleted K+-replete rat adrenal cortex (10, 11) , and demonstrated that rat P-450ado catalyzes three successive monooxygenation reactions of DOC to form aldosterone as a final product, whereas rat P-45011p does not substantially catalyze the reaction to form aldosterone. In regard to aldosterone biosynthesis in the human adrenal cortex, it has been postulated for a long time (12) (13) (14) 
45011p) [ as expressed in COS-7 cells exhibits steroid 18-hydroxylase activity to catalyze the synthesis of aldosterone and 18-oxocortisol and exhibits steroid 11,-hydroxylase activity as well. In contrast, P-45011p as expressed in the cultured cells exhibits steroid ilp-hydroxylase activity exclusively but fails to catalyze the synthesis of aldosterone and 18-oxocortisol. These results indicate that P-450hlp and P-450cls are products of two different genes and that the former participates in the synthesis of glucocorticoids whereas the latter participates in the synthesis of mineralocorticoids in humans.
Aldosterone, the most potent mineralocorticoid, is synthesized via enzymatic reactions involving several specific monooxygenases (1), termed P-450 (2), starting from cholesterol and proceeding through a pathway including pregnenolone, progesterone, ll-deoxycorticosterone (DOC), and corticosterone as metabolic intermediates (3) . The molecular nature of the enzyme that catalyzes the final step of aldosterone biosynthesis is not fully understood. It has been postulated that steroid 11,B-hydroxylase (P-450119), a product of CYPJ1B (4) , is the enzyme responsible for the biosynthesis of aldosterone (5-7), because P-45011p purified from bovine adrenocortical mitochondria catalyzes the conversion of corticosterone to aldosterone via 18-hydroxycorticosterone (5), in addition to its main function, catalysis of the 11/3-hydroxylation of DOC to form corticosterone. In contrast, Ogishima et al. (8) and Lauber and Muller (9) recently isolated aldosterone synthase cytochrome P-450 (P-450ado), which is induced in Na+-depleted K+-replete rat adrenal cortex (10, 11) , and demonstrated that rat P-450ado catalyzes three successive monooxygenation reactions of DOC to form aldosterone as a final product, whereas rat P-45011p does not substantially catalyze the reaction to form aldosterone.
In regard to aldosterone biosynthesis in the human adrenal cortex, it has been postulated for a long time (12) (13) (14) that two types of enzymes, corticosterone methyl oxidases type I (CMO I) and type II (CMO II), are involved in the final two steps of aldosterone synthesis, because several acquired and inborn errors in the synthesis or action of aldosterone (e.g., CMO II deficiency: hypoaldosteronism with elevated excretion of 18-hydroxycorticosterone and elevated level of plasma renin activity) cannot be explained by functional anomaly of P450110 (13) . Nevertheless, such CMOs have not been isolated.
Recently, we reported the isolation of two cDNAs coding for human P-450lpf (15) and human steroid 18-hydroxylase [P-45OC18 (16); formerly designated P-450awdo (17) ITo whom reprint requests should be addressed. ' The sequences reported in this paper have been deposited in the GenBank data base (accession nos. D90428 and D90429).
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gene was isolated from a human Charon 4A genomic DNA into the HindIII site of pSVOOCAT (24) . DNA transfection library (ref. 22 ; supplied by the Japanese Cancer Research and CAT assay were as described (15, 17) . Resources Bank) by using the same probe as that used for Analysis of Steroid Hydroxylase Activity ofP-450s Expressed cloning P-450c18 cDNA (16, 17) . The nucleotide sequence in COS-7 Cells After Transfection. Expression plasmids conwas determined by the dideoxy method (23) .
taining P-45011p cDNA (pSV11,) and P-450c18 cDNA Chloramphenicol Acetyltransferase (CAT) Assay. The 5' (pSVC18) were constructed as described (17 AGTGAACATAAATATTTTCTCAGGTAAATAAAAATTGAGGGGATTCGCTGCCAATAGAACTGACTTGCCAGAAATGTTTTTTAAAAGTTCTGCAGAGAG --AAAGAAAATGATACA ----1871 *** * * * ***** * *** * ** *** *** ** ** ** ** ** * * *** ***** ** *** * ** * **** AGT--ATTTTATTCTCTT-TGAAGCAATTGTGAA ---TGGGAGTTCACT ---CAT-GATTTGGCCTCTCTG-TTTGTCTGTTAAGGGTGTATAAGAATGCTTGTGATTTTTGTACATTGA -1848
GTCAGCAACCCTGAGCTACATAAAGAAAGGAAGAGCATTTCAGAAGGAATCAGTAAAGAGAAAATGAAGTCTTTTATTTTTTC -TTAATCTTAAT -T6ATCTA -A6AGTTT6CTAAAACA -17 53 * * *** ***** * *** * * ** * * ** * * **** **** ** ** ** * ** * ** * * ** * **** * *
TTTTGTATCCTAGAGCTTGCTGAAG--TTGCTTATCAGCTTAAGGAGATTTTGGGCTGAGACAATGGGGTTTTCTAGATATACAATCATGTCCGTCTGCCAAACAGAGACAATTTGACTT -1730
AAACMCAACAATAAAAATAG6CCGG6CGC66T6ACTCACCACACCTGTAAT -CCCA6CACTTTG66A66CC6A6GT6G6CAGATCACCT6A66TCA66A6TTC6A6ACTAG-CCTGGCC -1635 * * * **** * * * * * ** * **** ** ** * * * ** ** **** ** *** * ** * * ** CCTCTTTTCCTAATTGAATACCCTTTATTTCCTTCTCCT6CCTAATTGCCCT6GCCA6AAC -TTCCAACACTATGTT6AATAG6AGTG6TGAGAGAGGGCATTCCTGTCTTGTACCA6CT -1 611
AACACGGTGAA---ACCCCGTCTCT-ACTAAAAATACAAAAATTAGC--TGGGCGTGGTGGTGGCACATGCCTGTAATCCCAGCTACTTGGGA -----GGCTGA-GGCGGGAGAATTGCT -1527 *** **** ** ** * **** * * *** ** **** ** * * * ** * ** *** * * ** * **** ** * TTCACAGGGAAT6CTTCCAGTTTTTGACCATTCAGTATGATATT6GCT6TGGGTTTGCCATAGATAGCTCTTATTATTTTGA6ATAC6TCCCATCAATACCTAATTTATTGAGA6TTTTT -14 91
TGAACCCGGGAGACAGAGGTCGCAGTGAGCCGAGATC -ACACCATTGCACTCTAGCCTG-GGCGACAGAGTGAGACTCTGTCTCAAAAATAAATAAATAAATAAATAAATAAATA-ATAA -1410 * ** ** * ** * ** ** * * * * *** ** * * * ***** * * * ** ** ** ** ** * ***
AGCGTGAAGGTTGTTGAATTTTGTCAAAGGCCTTTTCTGCATCTATTGAGATAATCATGTGGTTTTTGTCTTTGGTTCT6TTTATATGCTGGAT---TACATTTATTGATTTGCATATAT -1374
AAATAAATAAATAAAA6CCA6AAA6TGTATTTGATGATCATAGTTATGTATATGTGAAATGAAG6ACAGCAATGAT6CAA66GATGG6TGAGTGGAATTAAAAATATCTTATTATTTATT -129 0 * * * * **** * ** * * * ** * ** *** * *** * * ** *** * ** ** * * *** * ** ** * * **
TGAACCAGCCTTGCATCCCAGGGA-TGAAGCCCA-CTTGATCATGGTGGATAAGCTTTTTGATGTGCTGC-TGGATTC--GGMTGCCAGTATTTTATTGAGGATTTTTGCATCAATGTT -1259
TAT-TTTGAGATGGAGTCT-TGCTTTGCTGCCCAGGTTGGAGTGCAGTGGGATGATCTCMCTCACTGCAACCTCCGCCTCCTTGATTCA ----AGCATTCATCTTGACTCAGCCTGCTGA -1175 ** ** ** ***** ** ** **** *** * ** * ** *** * ***** * * ** ** ** *** ** *** CATCAA6GATATTG -GTCTAAAATTCTCTTTTTTGGTT-G6TGT -CTCT6CCCGGCTTT6GTATCAGGAT6AtGCTGGCCTCATAAAATGAGTTAGGGAGGATTCCCTCTCTTTCTATTGA -1142 -~~~~~~~~~~~~~~~~~~~~~~14
GAAGCCGAGATT--ACAGGCAT-CGCCA-CCACACCTGGCTAATTTT6TAT-TTTTAGTAGAGACAGGGTTTTGCCATGTTGGCCAGGCTGGTCTCGAACTCCTGACCTCAGGTGATCC -1060 * ** ** *** ** * *** * *** * * ***** ** * * ** * * ***** * * * * * * *** * * ** * TTGGAATAGTTTCAGAAGGAATGGTACCAGTTCCTCCTTGTACGTCTGGTATAATTCGGCTGTGAATCCATCTGGTCATG--GACTCTTTTTGGTTGGTAATCTATTGATTA -TTGCCAC -1025
ACCTGCATCAGCCTCCCAAAGT6CTGGGATGACAGACAT6AGCCACTATGCCCAGCCTAAGAATATCTGATGATTATA -AAGTGCTTGCATTACCTCTGAAGCT6TATAGT6TTATATGA -941 * * ** * *** * * ** ** * ** * * ** ** * ** *** * * * * * **** **** * * ***** **** ** AATTTCA -GATCCTGTTATTGGTCTATTCAGAGATTCAACTTCTTACT66TTTAGTCTTGGGAGAGT6TAT6T6TC6A6GAATTTATCCATTTCTTCT -AGATTTTCTAGT -TTATTTG --909
A6GT6GAGTTGGAGAGATGAGT -TTTAAGCGTATATTGCAAACTCTA66GCAACCACTAAAGAAGT6AGACCCAGCCTCTAGAAAAAAAAAAAAAAAAGGAAATTAGCTATCAAGCCACG -822 ** *** ** * ** * ** *** *** * *** ** * * * **** *** *** ** * * *** * *** * * -CGTAGAGGTGTTTGTAGTATTCTCTGATGGTAGTTTG-TATTTCT-GTGGGATCGGT -----GGTGATATCC--CCTTTA --TCATTTTTTATTGCATCTATTTGAT-TCTTCTCTC--804 AAAAGAAATGGAGGAACCTTAAAC6CATATTACTAACT6AGATAC6TCACTTTGAAAA6GCTACAAACGGT6TCATTCCAACTATACAACATTTTGGAAAAGGCCAAAGCATGGT6ATGA -702 * * * *** ** ** ** * * * ** ** **** * * ** ***** * * * **** * * * * * * TTTTTTTCTTTATTAGTCTTGCTAGCGGTCTATCAATTTTG -TT6ATCCTTTCAAAAAACCAGCTCCTGGATTCATTAATTTTTTGAAGGGTTTTTTGTGTCTCTATTTCCTTCA6TTCT -685
GCACTGATTTTAGTTATTTCTT6CCTTCTGCTAGTTTTGAAT6T6TTTGCTCTT6CTTTTCTAGTTCTTTTAATTGT6AT6TTAGGGTGTCA6TTTTGGATCTTTCCTGCTTTCTCTTGT -565
GGGATACAAATTACATACATTTGTCAAAACCCACAGC -AT6-TTGACCACCAGGAGGAGACCCCAT6-TGACTCCAGGACCCtGGTT6ATAACAA -CGTATC6AGATTCCTCACATGGAA -4 74 ** * * ** **** * ** ** ** ***** *** ** * *** ** ** * ****** *** ** * *** ** * * GGGCATTTAGTGCTATAAATTTCCCTCTACACACTGCTTT6AATGT6TTCCA -GAGATTCT66TAT6CTGTGTCTTT6-TTCTC6TT6GTTTCAAGAACATCTTTATTTCTGCCTTCATT -44 7 * ** ** ** ** ** ** * * *** **** * * ** ** ***** ***** ** * *** *** * *** **** * **** * *
CCAGTGCG-CCTTGGAGTTCTTTAGCGGGAGGAATTTCGTTGTATTGATACAAC-TGAAAAAATT-356
TTGTTACGTACCCAGTAGT -CATTCAGGAGCAG -GT-TGCTCAG --TTTCCATGTA ---ATTGAGCGGTTTTGAGTGAGTTTCTTAAT-CCTGAGTTCTAGTTTGATTGCACTAAAATTT -336
ATTAAAAGAATCCAAGGCTCCCTCTCATCT --CACGA -TAAGATAAAGTCCCCATCCATTTTACTCCTCTCAGCCCTGGAGAAAGGAGAGGCCAGGTCCCACCACCTTCCACCAGCATGG -239 * ***** * ** *.* ** * * ** * ** ** ** * *** * ** ** ** *** ****** * *** * *** * ** * TTAAAAAGTA-AAAAAAATACATGTGGTTTAATACAATTCATGCCAACTCATTCCCTCGTTTTTTGCTATAAACCTTGCA ---AGGAGATGAATAATCCAAGGCTCTTGGATAAGATAAG -220
ACCCCCA6TCCAGACCCCACGCCTTTTCTCAGCATCCTCAGACCAGCAGGACTTGCAGCAATGGGGAATTAGGCACCTGACT--TCTCCTTCATCTACCTTTGGCTGGGGCCTCCAGCCT -121 *** *** * ** *** ***** ** * **** * ** * * * * * **** ** *** * ** * * * * ********** GGCCCCA --------TCCA--TC-TTGCTC ---CTCTCAGCCCTGGAGGA---GGAGGGA --GAGTCCTTTTCCCCTGTCTACGCTCATGCACCCCCAATGAGTCCCTGCCTCCAGCCC -120 T6ACCTTC6CTCTGA6AGTCTCAGGCAGGTCCA6AGGCCAGTTCTCCCATGACGTGATATGTTTCCA6A6CA66TTCCTGGGTGA §ATAAAAGGATTTGGGCTGAACAGGGTGGA6G6AG
-1 ****** ** ** * ********** ***** *********************** * * * *** * * ** ************* ******************** T6ACCTCTGCCCTCG6TCTCTCAGGCAGATCCAG -GGCCAGTTCTCCCATGACGTGATCCCTCCCGAAGGCAAGGCACCAGGCAAGATAAAAGGATTGCAGCTGAACAGGGTGGAGGGAG -1
MetAl a LeuArgAl a LysAl aG6 uVal CysVal Al aAl aProTrpLeuSerLeuGl nArgAl aArgAl aLeuGlyThrArgAl aAl aArg.....
CATTGGAATGGCACTCAGGGCAAAGGCAGAGGTGTGCGTGGCAGCGCCCTGGCTGTCCCTGCAAAGGGCACGGGCACTGGGCACTAGAGCCGCTCGGG. -************************************* ****** ************************** ************ ******** **** CATTGGAATGGCACTCAGGGCAAAGGCAGAGGTGTGCATGGCAGTGCCCTGGCTGTCCCTGCAAAGGGCACAGGCACTGGGCACGAGAGCCGCCCGGG . (17) , and protein concentration was determined (27) . To check the purity of the mitochondrial fraction, succinate dehydrogenase activity was determined (28) . To quantitate the amounts of P-45011p and P-450c18 expressed in mitochondria of COS-7 cells, Western blot analysis (29) was performed using anti-bovine P-45011, IgG and 125I-labeled protein A. Steroid hydroxylase activity was measured (17) using a1 mg of solubilized mitochondria. Radioactive products were analyzed (5) by reverse-phase HPLC on a Wakosil 5C18 column (4.6 x 250 mm) with a mobile phase of aqueous 60% methanol at a flow rate of 0.3 ml/min.
RESULTS
In the first experiment, we attempted to isolate P-4501113 and P-450c18 genes from two types of human genomic DNA libraries in order to examine whether the two genes were identical with CYPJJBI and CYPJJB2 (18) , respectively. identical (see Fig. 1 examined with or without 8-bromo cAMP in steroidogenic BeWo choriocarcinoma cells and in nonsteroidogenic HeLa cells, but no promoter activity was detected using any of the deletion mutants ( Fig. 2 C and D) . These results indicate that the two genes are regulated differently and that their expression might be highly specific in the cells derived from the adrenal cortex.
To definitively clarify the functional characteristics of the products encoded by the P-450119 gene and the P-450c18 gene, expression plasmids (pSV11,8 and pSVC18) with the 33 differences per 503 amino acid residues in both coding regions (16, 17) were transfected into COS-7 cells, and steroid hydroxylase activity and the amounts of these two P-450s expressed were determined. The amounts of P-45011,9 (Mr 50,000) and P-450c18 (Mr 48,500) expressed in mitochondria of COS-7 cells were essentially the same as judged by Western blot analysis (Fig. 3) . The 11,8-hydroxylation of DOC or deoxycortisol to form corticosterone or cortisol catalyzed by these two P-450s proceeded to a similar extent (Table 1) . No detectable amounts of the 18-oxo products, aldosterone and 18-oxocortisol, were formed in the presence of P-45011,9. In contrast, P-450c18 catalyzed the formation of the 18-oxo products. In addition, P-450c18 catalyzed the formation of the 18-hydroxy derivatives of corticosterone and cortisol to a much greater extent than P-45011p. On the basis of these findings, Fig. 4 summarizes the metabolic pathways and enzymes involved in the biosynthesis of glucocorticoids and mineralocorticoids in humans. P-45011s catalyzes mainly reaction step 5, and P-450c18 catalyzes steps 6 and 7 in addition to step 5.
DISCUSSION
We have isolated and characterized two genes for the biosynthesis of corticoids, one coding for P-450119 and the other coding for P-450c18. At first glance, Table 1 might be interpreted to indicate that P-450c18 plays a major role in the synthesis of both glucocorticoids and mineralocorticoids in vivo as well as in vitro. However, cortisol synthesis occurs predominantly in the zona fasciculata of the adrenal cortex and is controlled by corticotropin, whereas aldosterone is synthesized exclusively in the zona glomerulosa under the control of the renin-angiotensin system. P450c18 catalyzes the synthesis of aldosterone, the most potent mineralocorticoid in humans. Thus, the major physiological function of P-45OC18 involves the synthesis of mineralocorticoids. Our current interpretation (Fig. 4) is that 18-hydroxylase activities of P-450c18 involved in steps 6 and 7 correspond to CMO I activity and CMO II activity, respectively. A detailed molecular genetic analysis of CMO I and CMO II deficiencies should provide a definitive answer to the above interpretation.
In regard to nomenclature of P-450s in steroidogenesis, we emphasize that the term "P450c18" should be used in place ofthe term "P-450ado" as previously proposed (16) . The term P45Oado was originally used by Ogishima et al. (8) for the P450 catalyzing the formation of aldosterone in rat, in which the cortisol synthetic pathway (see Fig. 4 ) is not operative due to lack of steroid 17a-hydroxylase. Further, the suffix letters (SCC, C21, 17a, 1113, and AROM) employed for the other five P450s involved in the biosynthesis of steroids represent the enzymatic reactions catalyzed by these P450s and they do not represent the reaction products formed. In other words, each suffix indicates which carbon atom or which moiety of steroids is modified by each P450. In the case of the enzyme under discussion here, its main feature and physiological function lie in its ability to catalyze 18-hydroxylation of corticosterone and cortisol to finally produce aldosterone and 18-oxocortisol. Therefore, the term P450c18 is more comprehensive and suitable than the term P450aldo for a better understanding of the biochemical features of this enzyme.
Note Added in Proof. After this article was accepted Curnow et al. (32) reported that CYPIJB2 is the gene for the aldosteronesynthesizing enzyme and that expression of the gene is regulated by angiotensin II. Therefore, these observations strongly support our previous (16, 17, 33 ) and current conclusion.
